Rosacea Sunscreens
Patient guide by Dr. Cleckley, Dermatologist, FACD.

"Sunscreen is amazing for rosacea – if you get it right!"

Rosacea and Sunscreen References

New 2016 — Public Proof About Zinc

The Basics of Real Sunscreen Therapy

Sunscreen Selection Guide

Suggested Sunscreens

Application Suggestions

Solar Wavelengths

Index of Chemicals

Useful Antioxidants

Adverse Effects

Vitamin D

References

About Dr. Cleckley and This Site

Tan, J. K. L., Girard, C., Krol, A., Murray, H. E., Papp, K. A., Poulin, Y., ... & Jeandupeux, D. (2002). Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea. Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology, 6(6), 529-534.

Nichols, K., Desai, N., & Lebwohl, M. G. (1998). Effective sunscreen ingredients and cutaneous irritation in patients with rosacea. Cutis; cutaneous medicine for the practitioner, 61(6), 344.

Pelle, M. T., Crawford, G. H., & James, W. D. (2004). Rosacea: II. therapy. Journal of the American Academy of Dermatology, 51(4), 499-512.

Wilkin, J. K. (1999). Use of topical products for maintaining remission in rosacea. Archives of dermatology, 135(1), 79.

van Zuuren, E. J., Gupta, A. K., Gover, M. D., Graber, M., & Hollis, S. (2007). Systematic review of rosacea treatments. Journal of the American Academy of Dermatology, 56(1), 107-115.

Leyden, J. J. (2011). Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study. Journal of drugs in dermatology: JDD, 10(10), 1179.

Stiefel, C. W. (2006). U.S. Patent No. 7,022,332. Washington, DC: U.S. Patent and Trademark Office.

Gross, H. (2009). Sunscreen, antibiotics, laser. What can you do against rosacea?]. MMW Fortschritte der Medizin, 151(51-52), 18.

Nieuwenhuijsen, B. (2012). U.S. Patent No. 8,337,820. Washington, DC: U.S. Patent and Trademark Office.

Stiefel, C. W. (2002). WIPO Patent Application PCT/US2002/021535.

Guthery, E. B. (2010). WIPO Patent Application PCT/US2010/054322.

Naylor, M., & Farmer, K. (1998). The Case for Sunscreens Revisited—Reply. Archives of Dermatology, 134(4), 510-511.

Lindow, K. B., & Warren, C. (2001). Understanding Rosacea: a guide to facilitating care. AJN The American Journal of Nursing, 101(10), 44.

PERIER, V., & RINALDIN, S. (2008). WIPO Patent No. 2008129066. Geneva, Switzerland: World Intellectual Property Organization.

Diana Draelos, Z. (2001, September). Cosmetics in acne and rosacea. In Seminars in Cutaneous Medicine and Surgery (Vol. 20, No. 3, pp. 209-214). WB Saunders.

Gupta, A. K., & Chaudhry, M. M. (2003). Critical review of the manner in which the efficacy of therapies for rosacea are evaluated. International journal of dermatology, 42(11), 909-916.

Rone, M., & Kisis, J. (2002). A12. IPL therapy in the inflammatory stage of rosacea. Journal of Cosmetic Dermatology, 1(2), 108-108.

Matthews, L. What Causes Rosacea? Three Common Triggers and How to Combat Them.

Draelos, Z. D. (2010). Optimizing Redness Reduction Part I: Rosacea and Skin Care. Journal of the Rosacea Research and Development Institute: Volume 1 Number 1, 2010, 7.

Van Zuuren, E. J., Kramer, S. F., Carter, B. R., Graber, M. A., & Fedorowicz, Z. (2011). Effective and evidence?based management strategies for rosacea: summary of a Cochrane systematic review. British Journal of Dermatology, 165(4), 760-781.

Patt, L. M. (2005). U.S. Patent No. 6,927,206. Washington, DC: U.S. Patent and Trademark Office.

McAleer, M. A., Fitzpatrick, P., & Powell, F. C. (2010). Papulopustular rosacea: prevalence and relationship to photodamage. Journal of the American Academy of Dermatology, 63(1), 33-39.

Gooderham, M. (2009). Rosacea and its topical management. Skin Therapy Lett, 14(2), 1-3

JANCIN, B. (2007). Texting Patients May Boost Topical Tx Compliance. J Am Acad Dermatol, 56(5), 791-802.

Aksoy, B., Altaykan?Hapa, A., Egemen, D., Karagöz, F., & Atakan, N. (2010). The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. British Journal of Dermatology, 163(4), 719-725.

LAAS, M. (2008). Sunscreen Chemical ‘Widespread’in US Population. Skin & Allergy News.

Roebuck, H. L. (2005). Face up to rosacea. The Nurse Practitioner, 30(9), 24-35.

Ortiz, A. The Rosacea Dilemma.

Duteil, I., Queille-Roussel, C., Rougier, A., Richard, A., & Ortonne, J. P. (2002). High protective effect of a broad-spectrum sunscreen against tetracycline phototoxicity. European journal of dermatology: EJD, 12(4), X.

May, D., Kelsberg, G., & Safranek, S. (2011). What is the most effective treatment for acne rosacea?. Clinical Inquiries, 2011 (MU).

Dajani, Z., Swetter, S. M., Demierre, M. F., & Geller, A. C. (2005). Sun protection factor content and warning statements for sunless tanning products: an examination of retail outlets and the Internet. Journal of the American Academy of Dermatology, 53(5), 919-920.

Del Rosso, J. Q., & Baum, E. W. (2008). Comprehensive medical management of rosacea: an interim study report and literature review. The Journal of clinical and aesthetic dermatology, 1(1), 20.

Pereira, T. M., Vieira, A. P., & Basto, A. S. (2008). Rosacea with extensive extrafacial lesions. International journal of dermatology, 47(1), 52-55.

Schroeder, P., & Krutmann, J. (2010). What is needed for a sunscreen to provide complete protection. Skin Therapy Lett, 15, 4-5.

Ortiz, A. Rosacea Symptoms and Treatment.

Nash, K. (2011). Dermatologists review FDA's updated sunscreen guidelines.

Hewitt, J. P. (2009). New and Emerging Sunscreen Technologies. Clinical Guide to Sunscreens and Photoprotection, 43, 155.

Roebuck, H. L., & Siegel, M. T. (2009). Inflammatory rosacea: A triad plan of action. Journal of the Dermatology Nurses' Association, 1(1), 36-47.

Rosacea, E. (2009). Standard management options for rosacea, part 2: options according to subtype. Cutis, 84, 97-104.

McLean, D. I., & Gallagher, R. Sunscreen Controversies

Lavers, I. (2012). Rosacea-A Review of the Current Evidence. Dermatological Nursing, 11(4), 36-42.

González, S., & Gilaberte-Calzada, Y. (2009). Oral and Other Non-sunscreen Photoprotective Agents. Clinical Guide to Sunscreens and Photoprotection, 43, 207.

Muizzuddin, N., Marenus, K. D., & Maes, D. H. (2004). U.S. Patent No. 6,680,062. Washington, DC: U.S. Patent and Trademark Office.

Moyal, D., Binet, O., Richard, A., Rougier, A., & Hourseau, C. (1999, March). PREVENTION OF POLYMORPHOUS LIGHT ERUPTION BY A NEW BROADSPECTRUM SUNSCREEN: NEED FOR A HIGH UVA PROTECTING FACTOR. In Annual Meeting of the American Academy 0! Dermatology. 1999, New Orleans. Louisiana USA (Vol. 120).

Latha, M. S., Martis, J., Shobha, V., Shinde, R. S., Bangera, S., Krishnankutty, B., ... & Kumar, B. N. (2013). Sunscreening agents: a review. The Journal of clinical and aesthetic dermatology, 6(1), 16.

Zoe Diana Draelos, M. D. (2011). Relationship between sunscreen and aging, skin cancer, deserves scrutiny.

Shanler, S. D., & Ondo, A. (2013). U.S. Patent No. 8,420,688. Washington, DC: U.S. Patent and Trademark Office.

Landow, K. Unraveling the mystery of rosacea.

Van Onselen, J. (2012). Prescribing for mild-to-moderate rosacea. Nurse Prescribing, 10(1), 25-31.

Van Onselen, J. (2012). Rosacea: symptoms and support. British Journal of Nursing, 21(21), 1252-1255.

Gans, E. H. (2003). U.S. Patent Application 10/408,059.

Fallen, R. S., & Gooderham, M. (2012). Rosacea: update on management and emerging therapies. Skin Therapy Lett, 17(10), 1-4.

Vulgaris, A. (2012). Acne and Rosacea in Skin of Color. Skin of Color: A Practical Guide to Dermatologic Diagnosis and Treatment, 21.

Punsalan, T., & Usatine, R. P. (2005). Red facial rash with" granitos". Journal of family practice, 54(9), 777.

Vanbeek, M. J., Strauss, J. S., & Nygaard, I. (2005). Flushing and papules in a middle-aged woman. Obstetrics & Gynecology, 105(2), 397-401.

van Zuuren, E. J. (2013). Evidence-based topics in dermatology. Journal of the Bahrain Medical Society, 24(1).


Author: Jeremy Cleckley


Copyright 2013-2017. Dr. Cleckley. All Rights Reserved. Disclaimer. Contact/Feedback.